3
Total deals
$123.8M
Total value
$41.3M
Avg deal
$100.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Exosome Diagnostics
Exosome Diagnostics develops and commercializes blood-based cancer molecular dia…
|
2025-08-05 | Acquisition | Complete | $15.0M | Deal → |
| 2 |
Exact Sciences - Oncotype DX GPS Prostate Cancer Business
Exact Sciences - Oncotype DX GPS Prostate Cancer provide physicians and patients…
|
2022-08-02 | Acquisition | Complete | $100.0M | Deal → |
| 3 |
N
Noviogendix Holding
Noviogendix Holding is a provider of molecular diagnostics and services to physi…
|
2015-09-15 | Acquisition | Complete | $8.8M | Deal → |